Article Information
History
- May 15, 2021.
Article Versions
- You are currently viewing Version 1 of this article (May 15, 2021 - 15:48).
- Version 2 (August 10, 2021 - 13:54).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Alyssa Bilinski, MS1,
- Andrea Ciaranello, MD2,
- Meagan C. Fitzpatrick, PhD3,
- John Giardina, MA1,
- Maunank Shah, MD, PhD4,
- Joshua Salomon, PhD5 and
- Emily A. Kendall, MD, PhD4,*
- 1Harvard Graduate School of Arts and Sciences, Cambridge, MA
- 2Medical Practice Evaluation Center and Division of Infectious Disease, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts
- 3Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland
- 4Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD
- 5Center for Health Policy and Center for Primary Care and Outcomes Research, Stanford University School of Medicine, Stanford, California
- ↵*Corresponding author; email: ekendall{at}jhmi.edu